The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy
Permalink
Citation
Heymans , S , Eriksson , U , Lehtonen , J & Cooper , L T 2016 , ' The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy ' , Journal of the American College of Cardiology , vol. 68 , no. 21 , pp. 2348-2364 . https://doi.org/10.1016/j.jacc.2016.09.937
| Title: | The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy |
| Author: | Heymans, Stephane; Eriksson, Urs; Lehtonen, Jukka; Cooper, Leslie T. |
| Contributor organization: | Kimmo Kontula Research Group Clinicum Department of Medicine Kardiologian yksikkö |
| Date: | 2016-11-29 |
| Language: | eng |
| Number of pages: | 17 |
| Belongs to series: | Journal of the American College of Cardiology |
| ISSN: | 0735-1097 |
| DOI: | https://doi.org/10.1016/j.jacc.2016.09.937 |
| URI: | http://hdl.handle.net/10138/230026 |
| Abstract: | Myocarditis is a diverse group of heart-specific immune processes classified by clinical and histopathological manifestations. Up to 40% of dilated cardiomyopathy is associated with inflammation or viral infection. Recent experimental studies revealed complex regulatory roles for several microribonucleic acids and T-cell and macrophage subtypes. Although the prevalence of myocarditis remained stable between 1990 and 2013 at about 22 per 100,000 people, overall mortality from cardiomyopathy and myocarditis has decreased since 2005. The diagnostic and prognostic value of cardiac magnetic resonance has increased with new, higher-sensitivity sequences. Positron emission tomography has emerged as a useful tool for diagnosis of cardiac sarcoidosis. The sensitivity of endomyocardial biopsy may be increased, especially in suspected sarcoidosis, by the use of electrogram guidance to target regions of abnormal signal. Investigational treatments on the basis of mechanistic advances are entering clinical trials. Revised management recommendations regarding athletic participation after acute myocarditis have heightened the importance of early diagnosis. (C) 2016 by the American College of Cardiology Foundation. |
| Subject: |
heart failure
inflammasomes macrophages microRNAs sarcoidosis t-lymphocyte subsets viral infection GIANT-CELL MYOCARDITIS EXPERIMENTAL AUTOIMMUNE MYOCARDITIS COXSACKIEVIRUS B3-INDUCED MYOCARDITIS IDIOPATHIC DILATED CARDIOMYOPATHY CHAGAS-HEART-DISEASE CARDIOVASCULAR MAGNETIC-RESONANCE LEFT-VENTRICULAR DYSFUNCTION CLINICALLY SUSPECTED MYOCARDITIS POSITRON-EMISSION-TOMOGRAPHY ACUTE VIRAL MYOCARDITIS 3121 General medicine, internal medicine and other clinical medicine |
| Peer reviewed: | Yes |
| Usage restriction: | openAccess |
| Self-archived version: | publishedVersion |
Files in this item
Total number of downloads: Loading...
| Files | Size | Format | View |
|---|---|---|---|
| 1_s2.0_S0735109716364658_main.pdf | 1.724Mb |
View/ |
This item appears in the following Collection(s)
-
Articles from TUHAT CRIS [50500]
Related items
Showing items related by title, author, creator and subject.
-
(2022)The field of inflammatory disease of the heart or "cardio-immunology " is rapidly evolving due to the wider use of non-invasive diagnostic tools able to detect and monitor myocardial inflammation. In acute myocarditis, recent data on the use of immunomodulating therapies have been reported both in the setting of systemic autoimmune disorders and in the setting of isolated forms, especially in patients with specific histology (e.g., eosinophilic myocarditis) or with an arrhythmicburden. A role for immunosuppressive therapies has been also shown in severe cases of coronavirus disease 2019 (COVID-19), a condition that can be associated with cardiac injury and acute myocarditis. Furthermore, ongoing clinical trials are assessing the role of high dosage methylprednisolone in the context of acute myocarditis complicated by heart failure or fulminant presentation or the role of anakinra to treat patients with acute myocarditis excluding patients with hemodynamically unstable conditions. In addition, the explosion of immune-mediated therapies in oncology has introduced new pathophysiological entities, such as immune-checkpoint inhibitor-associated myocarditis and new basic research models to understand the interaction between the cardiac and immune systems. Here we provide a broad overview of evolving areas in cardio-immunology. We summarize the use of new imaging tools in combination with endomyocardial biopsy and laboratory parameters such as high sensitivity troponin to monitor the response to immunomodulating therapies based on recent evidence and clinical experience. Concerning pericarditis, the normal composition of pericardial fluid has been recently elucidated, allowing to assess the actual presence of inflammation; indeed, normal pericardial fluid is rich in nucleated cells, protein, albumin, LDH, at levels consistent with inflammatory exudates in other biological fluids. Importantly, recent findings showed how innate immunity plays a pivotal role in the pathogenesis of recurrent pericarditis with raised C-reactive protein, with inflammasome and IL-1 overproduction as drivers for systemic inflammatory response. In the era of tailored medicine, anti-IL-1 agents such as anakinra and rilonacept have been demonstrated highly effective in patients with recurrent pericarditis associated with an inflammatory phenotype.
-
(2020)Heart transplantation (HTx) for patients with "giant cell myocarditis" (GCM) or "cardiac sarcoidosis" (CS) is still controversial. However, no single center has accumulated enough experience to investigate post-HTx outcome. The primary aim of this systematic review is to identify, appraise, and synthesize existing literature investigating whether patients who have undergone HTx because of GCM or CS have worse outcomes as compared with patients transplanted because of other etiologies. A systematic and comprehensive search will be performed using PubMed, Scopus, Web of Science, EMBASE, and Google Scholar, for studies published up to December 2019. Observational and interventional population-based studies will be eligible for inclusion. The quality of observational studies will be assessed using the Newcastle-Ottawa scale, while the interventional studies will be assessed using the Cochrane Effective Practice Organization of Care tool. The collected evidence will be narratively synthesized; in addition, we will perform a meta-analysis to pool estimates from studies considered to be homogenous. Reporting of the systematic review and meta-analysis will be in accordance with the Meta-analysis of Observational Studies in Epidemiology Preferred Reporting Items for Systematic reviews and Meta-Analysis guidelines. To our knowledge, this will be the first synthesis of outcomes, including survival, acute cellular rejection, and disease recurrence, in patients with either GCM or CS treated with HTx. Reviewing the suitability of HTx in this population and highlighting areas for further research will benefit both patients and healthcare providers. Trial registration: CRD42019140574.
-
(2017)Background-Epidemiology of myocarditis in childhood is largely unknown. Men are known to have a higher incidence of myocarditis than women in adults aged Methods and Results-Data of all hospital admissions with myocarditis in Finland occurring in patients aged Conclusions-Myocarditis leading to hospital admission is relatively uncommon in children, but occurrence of myocarditis increases with age. There is no sex difference in the risk of myocarditis during the first 6 years of life, but boys have a significantly higher risk at ages 6 to 15 years.